- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Vertical Integration of Providers Top Consolidation Trend | Managed Healthcare Executive® State of the Industry Survey
A solid majority of respondents said vertical integration among providers is the consolidation trend that is most likely to accelerate this year.
Healthcare used to be a fairly decentralized sector of the economy with plenty of local doctors and hospitals. Large insurers such as UnitedHealth Group and Aetna are not new, but now they not just insurers. UnitedHealth Group owns Optum, an increasingly large “health services company,” and Aetna is part of CVS Health.
The Managed Healthcare Executive® State of the Industry survey asked which of the many consolidation trends in the sector is mostly to accelerate this year. A solid majority (58%) of the roughly 450 respondents picked vertical integration of provider organizations, such as hospitals and physician groups.
Only a small group (20%) indicated that they believed horizontal consolidation of provider organizations — hospitals combining with other hospitals, for example — would speed up this year. Even smaller groups of respondents (14% and 7%, respectively) picked horizonal and vertical consolidation of payers as likely to be speed up this year.
PBM Legislation and the PBM-affiliated GPOs | AMCP 2024
April 17th 2024Ross Margulies, J.D., M.P.H., a partner at the Foley Hoag law firm, discusses whether proposed transparency rules in the pharmacy benefit manager (PBM) legislation that Congress is considering might apply to the PBM-affiliated group purchasing organizations.
Read More
Providing Access to Rezdiffra for NASH and the Therapies to Come | AMCP 2024
April 16th 2024The pipeline for NASH treatments is robust, with six therapies in phase 3 development. Speakers at the annual AMCP meeting discuss Rezdiffra, the first drug approved specifically for NASH, and how to think about coverage issues.
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
